Stay updated on AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Sign up to get notified when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.

Latest updates to the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Added a Locations section listing California, New Jersey, and Oregon sites, with the page revision updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check60 days agoChange Detected- Removed the government funding status notice from the page. The core study details remain unchanged.SummaryDifference0.4%

- Check75 days agoChange DetectedThe observed changes are minor and do not affect core content or study objectives. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference3%

Stay in the know with updates to AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AGI-134 Safety & Tolerability in Solid Tumour Clinical Trial page.